Read the latest research on this blog

APS-Hughes
[ Home ] [ Up ] [ Schools ] [ Supplement Tests ] [ Request Letter ] [ Sample Release ] [ Suggestions ] [ Risks ] [ Recommended D Levels ] [ Onset Conditions ] [ Provigil ] [ Other Tests ] [ Ordering Piracetam ] [ No ISAC ] [ Medical Release ] [ Metformin ] [ Lupus anticoagulant ] [ MCS Dysfunction ] [ Malabsorbtion ] [ Relevant Experience ] [ Literature ] [ Lp(a) ] [ Lupus Antibodies ] [ Light Sensitivity ] [ Introduction ] [ Legal Issues ] [ Lapp ] [ Kutapressin ] [ Hughes Syndrome Testing ] [ Ancrod ] [ Experience ] [ Herxheimer ] [ Increasing Aldosterone ] [ Insomnia ] [ Infections ] [ Hypoxia ] [ New Page 1 ] [ Adrenal Connection ] [ Clopidogrel ] [ Coagulation ] [ Epidemics ] [ Anticoagulants ] [ Deficiencies ] [ EBV ] [ Dosing Protocols ] [ Disabilities ] [ Chelation ] [ Cheap Help ] [ Dave Berg ] [ Cheney ] [ Clinical Tests ] [ Circulation ] [ Berg ] [ Antibodies ] [ Antihistamines ] [ Antimalarials ] [ CFS Dysfunctions ] [ Candida ] [ Cacosmia ] [ Books ] [ Bananas ] [ APS-Hughes ] [ Antivirals ] [ Antithrombin III ] [ Angiotensin Receptor Blockers ] [ Anticoagulation ] [ Physicians ] [ Alopecia ] [ Allergies ]

The technical name for the type of hypercoagulation seen in CFIDS is "antiphospholipid antibody syndrome" or APS This has been recently changed to HUGHES SYNDROME. A search of Medline found the following information:

• "interleukin-6 produced by the myxoma(virus) could trigger an immunological reaction leading to the primary antiphospholipid syndrome"
• Helicobacter pylori can provoke APS
• Statins are an additional therapeutic tool in APS
• Allergies previously not seen can be associated with APS
• Infectious agents have been implicated in the development of the antiphospholipid syndrome (APS).
   

S

Enter your search terms

Web lassesen.com PubMed emedicine.com Submit search form

Home

Original 2001 WebSite as PDF for download

Looking for something, look in the Contents or do a Site Search